Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ultrasmall Renally Clearable Silica Nanoparticles Target Prostate Cancer.
Chen F, Ma K, Zhang L, Madajewski B, Turker MZ, Gallazzi F, Cruickshank K, Zhang X, Jenjitranant P, Touijer KA, Quinn TP, Zanzonico P, Wiesner U, Bradbury MS. Chen F, et al. Among authors: cruickshank k. ACS Appl Mater Interfaces. 2019 Nov 27;11(47):43879-43887. doi: 10.1021/acsami.9b15195. Epub 2019 Nov 13. ACS Appl Mater Interfaces. 2019. PMID: 31675204 Free PMC article.
Immunoengineering in glioblastoma imaging and therapy.
Zanganeh S, Georgala P, Corbo C, Arabi L, Ho JQ, Javdani N, Sepand MR, Cruickshank K, Campesato LF, Weng CH, Hemayat S, Andreou C, Alvim R, Hutter G, Rafat M, Mahmoudi M. Zanganeh S, et al. Among authors: cruickshank k. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Nov;11(6):e1575. doi: 10.1002/wnan.1575. Epub 2019 Aug 12. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019. PMID: 31407522 Review.
Assessment of Cardiovascular Disease Among Predominantly Black Gout Patients.
Chandrakumar HP, Puskoor AV, Chillumuntala S, Sharif S, Mora DC, Gupta T, Tadayoni A, Zonnoor SL, Celiker P, Yakoubovitch S, Tsai A, Chiu C, Kazi A, Freilich M, Saleh A, Moon SJ, Cruickshank K, Li S, Katz J, Eichler J, Salciccioli L, McFarlane IM. Chandrakumar HP, et al. Among authors: cruickshank k. J Clin Rheumatol. 2023 Jun 1;29(4):202-206. doi: 10.1097/RHU.0000000000001948. Epub 2023 Mar 6. J Clin Rheumatol. 2023. PMID: 36881837
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.
Bibollet-Ruche F, Russell RM, Ding W, Liu W, Li Y, Wagh K, Wrapp D, Habib R, Skelly AN, Roark RS, Sherrill-Mix S, Wang S, Rando J, Lindemuth E, Cruickshank K, Park Y, Baum R, Carey JW, Connell AJ, Li H, Giorgi EE, Song GS, Ding S, Finzi A, Newman A, Hernandez GE, Machiele E, Cain DW, Mansouri K, Lewis MG, Montefiori DC, Wiehe KJ, Alam SM, Teng IT, Kwong PD, Andrabi R, Verkoczy L, Burton DR, Korber BT, Saunders KO, Haynes BF, Edwards RJ, Shaw GM, Hahn BH. Bibollet-Ruche F, et al. Among authors: cruickshank k. mBio. 2023 Feb 28;14(1):e0337022. doi: 10.1128/mbio.03370-22. Epub 2023 Jan 11. mBio. 2023. PMID: 36629414 Free PMC article.
A multi-centered trial investigating gestational treatment with ursodeoxycholic acid compared to metformin to reduce effects of diabetes mellitus (GUARD): a randomized controlled trial protocol.
Lovell H, Mitchell A, Ovadia C, Pitrelli N, Briley A, Singh C, Marschall HU, Cruickshank K, Murphy H, Seed P, Williamson C. Lovell H, et al. Among authors: cruickshank k. Trials. 2022 Jul 19;23(1):571. doi: 10.1186/s13063-022-06462-y. Trials. 2022. PMID: 35854327 Free PMC article.
Author Correction: Development of spirulina for the manufacture and oral delivery of protein therapeutics.
Jester BW, Zhao H, Gewe M, Adame T, Perruzza L, Bolick DT, Agosti J, Khuong N, Kuestner R, Gamble C, Cruickshank K, Ferrara J, Lim R, Paddock T, Brady C, Ertel S, Zhang M, Pollock A, Lee J, Xiong J, Tasch M, Saveria T, Doughty D, Marshall J, Carrieri D, Goetsch L, Dang J, Sanjaya N, Fletcher D, Martinez A, Kadis B, Sigmar K, Afreen E, Nguyen T, Randolph A, Taber A, Krzeszowski A, Robinett B, Volkin DB, Grassi F, Guerrant R, Takeuchi R, Finrow B, Behnke C, Roberts J. Jester BW, et al. Among authors: cruickshank k. Nat Biotechnol. 2022 Jun;40(6):974. doi: 10.1038/s41587-022-01323-0. Nat Biotechnol. 2022. PMID: 35440781 Free PMC article. No abstract available.
Development of spirulina for the manufacture and oral delivery of protein therapeutics.
Jester BW, Zhao H, Gewe M, Adame T, Perruzza L, Bolick DT, Agosti J, Khuong N, Kuestner R, Gamble C, Cruickshank K, Ferrara J, Lim R, Paddock T, Brady C, Ertel S, Zhang M, Pollock A, Lee J, Xiong J, Tasch M, Saveria T, Doughty D, Marshall J, Carrieri D, Goetsch L, Dang J, Sanjaya N, Fletcher D, Martinez A, Kadis B, Sigmar K, Afreen E, Nguyen T, Randolph A, Taber A, Krzeszowski A, Robinett B, Volkin DB, Grassi F, Guerrant R, Takeuchi R, Finrow B, Behnke C, Roberts J. Jester BW, et al. Among authors: cruickshank k. Nat Biotechnol. 2022 Jun;40(6):956-964. doi: 10.1038/s41587-022-01249-7. Epub 2022 Mar 21. Nat Biotechnol. 2022. PMID: 35314813 Free PMC article.
77 results